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Abstract
Background: The expression of glucocorticoid-receptor (GR) seems to be a key mechanism in
the regulation of glucocorticoid (GC) sensitivity and is potentially involved in cases of GC
resistance or hypersensitivity. The aim of this study is to describe a method for quantitation of GR
alpha isoform (GRα) expression using real-time PCR (qrt-PCR) with analytical capabilities to
monitor patients, offering standard-curve reproducibility as well as intra- and inter-assay precision.
Results:  Standard-curves were constructed by employing standardized Jurkat cell culture
procedures, both for GRα and BCR (breakpoint cluster region), as a normalizing gene. We
evaluated standard-curves using five different sets of cell culture passages, RNA extraction, reverse
transcription, and qrt-PCR quantification. Intra-assay precision was evaluated using 12 replicates of
each gene, for 2 patients, in a single experiment. Inter-assay precision was evaluated on 8
experiments, using duplicate tests of each gene for two patients. Standard-curves were
reproducible, with CV (coefficient of variation) of less than 11%, and Pearson correlation
coefficients above 0,990 for most comparisons. Intra-assay and inter-assay were 2% and 7%,
respectively.
Conclusion:  This is the first method for quantitation of GRα expression with technical
characteristics that permit patient monitoring, in a fast, simple and robust way.
Background
Glucocorticoids (GC) are a vital class of steroidal hor-
mones that mediate profound and diverse physiological
effects in vertebrates. GC are key hormones in the regula-
tion of glucose homeostasis, but other essential functions
are assigned to GC as well, such as regulatory roles in
development and other metabolic pathways, stress and
immune responses, neurobiology, and programmed cell
death. In addition, corticosteroids are among the most
widely prescribed class of drugs, primarily for their anti-
inflammatory and immunosuppressive roles. They are
also used in many chemotherapy regimens for leukemias
and other cancers due to their critical capability to induce
apoptosis.
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Cortisol and its synthetic derivatives act upon the gluco-
corticoid receptor (GR), a member of the nuclear hor-
mone receptor superfamily of ligand-activated
transcription factors. Prior to ligand binding, GR is prima-
rily localized within the cytoplasm as an oligomeric com-
plex composed of one receptor polypeptide, two
molecules of heat shock protein 90 (hsp90), one mole-
cule each of hsp 70, hsp 56 (immunophilin) and hsp23.
When the hormone binds to the receptor, the GC-GR
complex undergoes conformational changes, followed by
dissociation from the hsp complex and dimerization of
the GR molecules. The activated GR dimer is translocated
into the nucleus and because of its high DNA affinity is
able to bind to a specific DNA sequence named glucocor-
ticoid response element (GRE), which is located in the
vicinity of the target-regulated gene. The GR-GRE complex
interacts with other components of the transcription
apparatus to either enhance or repress the expression of
the targeted gene [1-3].
There are several molecular mechanisms involved in glu-
cocorticoid resistance or hypersensitivity (reviewed by
Yudt, 2002) and GR expression seems to be a key one.
These mechanisms are important for the regulation of cell
and tissue-specific GC sensitivity, but they can be patho-
logically modified in clinical conditions such as AIDS,
glucocorticoid-resistant asthma, rheumatoid arthritis and
familial glucocorticoid resistance, among others [4-7].
Evaluation of GR expression in these conditions presents
critical restrictions and has been limited to research proto-
cols, partly due to analytical difficulties. Methods
employed so far include ligand-binding assays, northern
and western-blots and PCR. These methods could only
provide qualitative or semi-quantitative information and
a truly quantitative and reproducible evaluation of GR
expression was still needed. In this study, we describe a
quantitative real-time PCR (qrt-PCR) for GR alpha iso-
form (GRα) expression that is suitable for patient moni-
toring and can be easily reproduced.
Results
GRα and BCR (breakpoint cluster region) standard-curves
were very stable using five different standard preparations,
with maximum coefficient of variation (CV) of 10.3%
observed for GRα most concentrated standard-point. GRα
standard-curves presented CVs of 10.3%, 7.8%, 9.1%,
5.5% and 3.6% for the cycle-thresholds (Ct) obtained
with each standard (6 to 2 logs of Jurkat cells). On both
genes, standard-curves CV were greater at the most con-
centrated standard-points. BCR CV was smaller than those
observed for GRα CV in all standard-points and all stand-
ard-curves. Standards of 6 to 1 log of Jurkat cells pre-
sented, respectively, CV of their Ct of 4.5%, 2.7%, 3.1%,
2.7%, 1.9% and 0.9%. BCR standard-curves had greater
analytical sensitivity than GRα, with 10 EC/mL versus 100
EC/mL.
Linear regression analysis of pairs of standard-curves dem-
onstrated strong correlation for both genes. The smallest
Pearson correlation coefficient on GRα curves was 0.982,
but most of them were higher than 0.990. Two pairs of
BCR curves showed Pearson correlation coefficient of
1.000 (Table 1). Standard-curves slopes presented a CV of
7.3% for GRα and 3.7% for BCR (mean slopes of -0.279
and -0.271, respectively). Using the t-test, we found this
difference in GRα and BCR slopes not significant (t = -
0.819 with 8 degrees of freedom, P = 0.437).
Intra-assay precision was around 2% for both evaluated
controls. Cases 1 and 2 presented, respectively, mean
GRα-EU of 1.406 and 1.443, with SD of 0.030 and 0.027
and CV of 2.1% and 1.9%.
Table 1: Evaluation of the standard-curve stability on five different sets of standard constructs.
ABCDE
A 1.000 0.993 0.996 0.994 0.993
1.000 1.000 0.994 0.997 0.996
B 0.993 1.000 0.987 0.981 1.000
1.000 1.000 0.994 0.997 0.996
C 0.996 0.987 1.000 0.999 0.989
0.994 0.994 1.000 0.998 0.997
D 0.994 0.981 0.999 1.000 0.982
0.997 0.997 0.998 1.000 1.000
E 0.993 1.000 0.989 0.982 1.000
0.996 0.996 0.997 1.000 1.000
Pearson's coefficients of correlation of GRα and BCR standard-curves for the same pair of experiments are expressed in the upper and lower rows, 
respectively. A to E refer to different sets of standard constructs, from Jurkat cell culture, viable cell count, RNA extraction, cDNA synthesis, 
standard dilution and qrt-PCR for GRα and BCR with calculations.BMC Molecular Biology 2004, 5:19 http://www.biomedcentral.com/1471-2199/5/19
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Inter-assay precision was approximately 7% for both
cases. Cases 1 and 3 presented, respectively, mean GRα-
EU of 1.427 and 1.333, with SD of 0.088 and 0.104 and
CV of 6.2% and 7.8%.
The median GRα-EU values of case 1 were similar both in
intra and inter-assay evaluations, respectively, 1.402 and
1.414 (figure 1). This difference was not considered signif-
icant when we applied the Mann-Whitney Rank Sum test
(p = 0.847).
Discussion
Glucocorticoid resistance and hypersensitivity are deter-
mined by a number of factors such as intra-cellular hor-
mone concentration, GR expression levels, GRα/GRβ
heterodimerization, GR gene polymorphisms or muta-
tions and GC-GR-protein interaction, among others
[1,3,8,9]. One of the major factors affecting GC sensitivity
seems to be the expression of its receptor. However, there
were methodological difficulties regarding absolute quan-
titation of GR.
Binding assays were initially used to evaluate GR levels,
but this assay is labor-intensive (and therefore, more
error-prone), it assess only GR ligand-binding properties
in the cytoplasm, providing no information regarding GR
in the nucleus and requires the use of radioactive materi-
als. Western blot assays were developed to assess GR pro-
tein levels. Despite numerous efforts to make well-
characterized and specific antibodies, to date there are no
highly specific human monoclonal antibodies targeted to
GR isoforms, preventing the development of true quanti-
tative methods, such as ELISA [2,10]. Quantitative PCR
approaches were difficult until qrt-PCR was developed.
Quantitative real-time PCR assays are based on cycle-by-
cycle fluorescence monitoring of detectable PCR products
(e.g., using TaqMan probes) and analysis of amplification
during the exponential phase of PCR (for a review in qrt-
PCR, see Mocellin, 2003 [11]).
Three groups recently described qrt-PCR techniques for
GRα evaluation. DeRijk et al. developed Taqman evalua-
tion of GRα and GRβ, however they did not describe the
use of standard-curves or gene normalization [12]. Since
their group was investigating GRα/GRβ ratio in the hip-
pocampus, controls were produced using mixtures of PCR
products of each isoform quantified by agarose gel densi-
tometry. They found GRα/GRβ ratio of approximately
8300 in leukocytes and 14500 in hippocampal cells sug-
gesting a minor physiological role for GRβ in normal cells
from these tissues.
Boullu-Ciocca et al. evaluated GRα and GRβ expression
using real-time PCR in obese and control cases [13]. They
used 18S mRNA as a normalizing gene, but no standard-
curves or precision characteristics were described. Mono-
nuclear cells from control individuals showed GRα/GRβ
ratio of 32:1, much higher than that observed by DeRijk
and co-workers, and 9.2 and 2.6 in patients with
gluteofemoral and visceral obesity, respectively. The lack
Intra (A) and Inter-assay (B) precision evaluation of GRα expression Figure 1
Intra (A) and Inter-assay (B) precision evaluation of GRα expression Case 1 was evaluated in both situations. Bars 
indicate median values of GRα-EU (expression units). Intra-assay CV was 2.1% and 1.9% for case 1 and 2. Inter-assay CV was 
6.2% and 7.8% (cases 1 and 3).BMC Molecular Biology 2004, 5:19 http://www.biomedcentral.com/1471-2199/5/19
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of information about test precision makes interpreting the
difference observed in the GRα/GRβ ratio among the two
groups very difficult.
Pedersen and Vedeckis evaluated two cell lines using real-
time PCR for seven different isoforms of GR (GRα, GRβ,
and exon 1 splicing variants: 1A1, 1A2, 1A3, 1B, 1C), total
GR (using exons 5–6) and 18S mRNA as normalizing gene
[14]. Standards were plasmid constructs for each isoform.
They observed a 1000-fold difference of GRα to GRβ
expression levels and that the major exon 1 splicing tran-
scripts are 1A3, 1B and 1C. Although elegantly designed,
the authors conclude that their technique presents exces-
sive variability for routine use. They estimated intra-assay
CV to be 13%, inter-assay to be ca. 4%, inter-standard to
be ca. 8% and overall CV of 15%. The test performance
data was presented in a very succinct way and it was not
possible to establish how inter-assay CV was calculated
neither how inter-assay CV was smaller than intra-assay.
The aim of this study was to describe and validate the
reproducibility for clinical monitoring of absolute quanti-
tation of glucocorticoid receptor alpha isoform using real-
time PCR. Our approach used a standardized procedure
for Jurkat cell culture to make cDNA standards for both
GRα and BCR. Standard-curves were reproducible, with
less than 11% CV for all standards used and Pearson cor-
relation coefficient above 0.990 for most comparisons.
Intra-assay and inter-assay precision were 2% and 7%,
respectively.
The BCR gene, derived from normal chromosome 22, was
chosen as an appropriate endogenous control. The gene is
ubiquitously expressed, has no reported pseudogenes and
is a stringent control for the detection of degradation of
RNA [15,16]. We found our approach to standard-curve
construction to be an advantage of our method, since GRα
and BCR were equally affected during all phases of stand-
ard construction. Another probable factor for achieving
the precision reported is the similar expression levels and
amplification rates of GRα and BCR.
Conclusions
In conclusion, we described for the first time a method for
quantitation of GRα expression with technical character-
istics that permit patient monitoring, in a fast, simple and
robust way.
Methods
Standards
We developed standards for real-time quantitation of GRα
expression by employing standardized Jurkat (E6-1 clone,
ATCC) cell culture. Jurkat cells were grown in RPMI 1640
(Gibco) supplemented with 10% FBS, 1% penicillin-
streptomycin (Gibco), 5% CO2 at 37°C. Culture medium
was changed every 72 h, by centrifugation at 500 rpm for
5 min and 10 mL of fresh medium was added. Viable cells
were counted in a hemocytometer (Neubauer chamber)
using Trypan Blue (Sigma) and re-suspended to obtain a
final density of 105 cells per milliliter. This procedure was
repeated three times and 24 hours after the third medium
exchange, cells were re-suspended to a final density of a
106 cells per milliliter. This strict protocol is necessary to
ensure RNA extraction on the log phase of cell growing
phase in order to minimize the variation of mRNA
expression.
Controls
Three normal individuals participated in this study, in
accordance with the guidelines proposed in The Declara-
tion of Helsinki and approved by the ethics committee of
our institution. Cases 1 and 2 are 30 and 32 year-old
females, respectively, and case 3 is a 9 year-old boy.
Heparinized blood was collected by venipuncture. After
collection of 20 mL blood, mononuclear cells were sepa-
rated using Histopaque-1077 (Sigma) by density gradient
separation after centrifugation at 1750 rpm for 30 min-
utes. Cells were washed and re-suspended in PBS and 10%
DMSO (Sigma) was added before freezing at -80°C. Prior
to RNA extraction, DMSO was removed by PBS washing
and re-suspension.
RNA isolation and cDNA synthesis
Total RNA was isolated from cells using guanidinium thi-
ocyanate-chloroform extraction (Trizol, Gibco), accord-
ing to the manufacture's recommendations. RNA was
dissolved in DNAse-RNAse-free water (Gibco), after
which the OD 260/280 was confirmed as >1.7, allowing
the estimation of RNA concentration. RNA was stored at -
80°C when the RT step was not immediate. cDNA was
synthesized from 1 µg of total RNA, using TaqMan
Reverse Transcription reagents (N808-0234, Applied Bio-
systems) with 1 × buffer, 5.5 mM MgCl2, 500 mM each
dNTP, 2.5 mM random primers, 1.25 U/mL reverse tran-
scriptase (Multiscribe reverse transcriptase) and DNAse-
RNAse-free water as needed. After 10 minutes at 25°C,
reaction was carried at 48°C for 30 minutes, followed by
enzyme inactivation at 95°C for 5 minutes.
Standard preparation
Jurkat cell cDNA was serially diluted in 1:10 ratio with
DNAse-RNAse-free water in order to obtain 6 logs of
standards from one million cells per millimeter to ten
cells per milliliter. They were numbered accordingly to
their log number (6 to 1).
Real-Time PCR quantitation
GRα primers and probes were designed with Primer
Express v.1.5 (Applied Biosystems) and both GRα and
BCR (a normalizing gene) primers sets target two differentBMC Molecular Biology 2004, 5:19 http://www.biomedcentral.com/1471-2199/5/19
Page 5 of 7
(page number not for citation purposes)
exons, in order to prevent genomic amplification. BCR
primers were previously used by Branford et al and our
group [16,17]. Primers and probes used are indicated in
figure 2.
PCR conditions were equal for both genes, using TaqMan
PCR Core kit (N808-0228, Applied Biosystems). Briefly, 1
× TaqMan buffer A, 500 µM each dNTP, 4.5 mM MgCl2,
200 nM of each primer, 100 nM of probe, 0.025 U/µL of
AmpliTaq Gold, 5 µL of cDNA and water were incubated
in a total volume of 25 µL. Cycle conditions on an ABI
7700 (Applied Biosystems) were: 95°C for 10 minutes
(AmpliTaq Gold activation) followed by 45 cycles of
95°C for 15 seconds (denaturation) and 60°C for 90 sec-
onds (annealing and extension). No template controls
and duplicates of each standard, for both genes, were used
in each run. Results were exported to MS-Excel to perform
linear regression analysis for each gene, determining a
standard-curve for Log of EC (equivalent of cells) based
on the average Ct of duplicates (fig. 3).
The average Ct for each sample was employed in the linear
regression equation in order to obtain the EC, for each
gene. Then, GRα-EC was divided by BCR-EC in order to
establish the GRα-EU (Expression Units).
Standard-curve evaluation
In order to evaluate standard-curve stability with this
process, we used five different sets of cell culture passages,
trypan blue viable cell counting, RNA extraction, cDNA
Primer and probe hybridization sites for each transcript Figure 2
Primer and probe hybridization sites for each transcript. The 5' end of the TaqMan probe is labeled with the reporter 
dye and the 3' end with the quencher dye. GRα stands for glucocorticoid receptor alpha isoform and BCR for breakpoint clus-
ter region, used as a normalizing gene.
GAAGGAAACTCCAGCCAGAACTGGCAGCGGTTTTATCAACTGACAAAACTCTTGGATTCTATGC
CTTCCTTTGAGGTCGGTCTTGACCGTCGCCAAAATAGTTGACTGTTTTGAGAACCTAAGATACG
ATGAGGTGGTTGAAAATCTCCTTAACTATTGCTTCCAAACATTTTTGGATAAGACCATGAGTAT
TACTCCACCAACTTTTAGAGGAATTGATAACGAAGGTTTGTAAAAACCTATTCTGGTACTCATA
TGAATTCCCCGAGATGTTAGCTG
ACTTAAGGGGCTCTACAATCGAC
1. GRα cDNA Sequence
2. BCR cDNA Sequence
CCTTCGACGTCAATAACAAGGATGTGTCGGTGATGATGAGCGAGATGGACGTGAACGCCATCGCAGG
GGAAGCTGCAGTTATTGTTCCTACACAGCCACTACTACTCGCTCTACCTGCACTTGCGGTAGCGTCC
Exon 18 Exon 19
Exon 8 Exon 9 alpha
GRα forward primer
Q R
GRα reverse primer
TaqMan GRα Probe
R
Q TaqMan BCR Probe BCR reverse primer
BCR forward primerBMC Molecular Biology 2004, 5:19 http://www.biomedcentral.com/1471-2199/5/19
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synthesis and qrt-PCR. These standard-curves sets were
named A to E. We calculated the mean, SD and CV for
each standard, the CV for standard-curves slopes, as well
as Pearson correlation coefficient for each pair of curves.
Precision evaluation
Intra-assay precision was evaluated in a single experiment
that included standard-curves for each gene and 12 repli-
cates for each gene, in samples obtained from two normal
controls (1 and 2). In order to calculate GRα-EU, pairs of
samples (GRα and BCR) were established according to
their position on the thermocycler.
Inter-assay precision was evaluated over eight different
experiments, each one with its own standard-curve and
duplicates of each gene, with samples obtained from two
normal controls (1 and 3). Duplicates were averaged for
calculation of GRα-EU.
Statistical analysis
Standard-curves and GRα-EU were calculated on MS-Excel
2000 for Windows. Linear regression of standard-curves
pairs was calculated using SPSS 10.0 (SPSS, Chicago). For
comparison of intra and inter-assay results of case 1, we
employed Mann-Whitney Rank Sum test on SigmaStat
v.2.03 (SPSS, Chicago), which was also used to perform
the t-test. Differences of p < 0.05 were considered statisti-
cally significant.
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